ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,594,123 | +5.1% | 132,429 | +19.1% | 0.03% | +14.8% |
| Q2 2023 | $3,418,565 | -14.4% | 111,209 | +0.3% | 0.03% | -20.6% |
| Q1 2023 | $3,994,070 | -20.2% | 110,854 | -12.4% | 0.03% | -22.7% |
| Q4 2022 | $5,003,825 | +30.2% | 126,615 | +32.4% | 0.04% | +25.7% |
| Q3 2022 | $3,843,000 | -24.5% | 95,638 | -21.0% | 0.04% | -12.5% |
| Q2 2022 | $5,090,000 | -0.2% | 121,058 | -7.5% | 0.04% | +29.0% |
| Q1 2022 | $5,101,000 | -11.5% | 130,932 | -9.5% | 0.03% | +3.3% |
| Q4 2021 | $5,765,000 | +33.9% | 144,665 | +21.4% | 0.03% | +15.4% |
| Q3 2021 | $4,307,000 | +1057.8% | 119,189 | +1214.7% | 0.03% | +1200.0% |
| Q2 2021 | $372,000 | – | 9,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |